295 related articles for article (PubMed ID: 19190519)
1. Risk of intracranial hemorrhage and cerebrovascular accidents in non-small cell lung cancer brain metastasis patients.
Srivastava G; Rana V; Wallace S; Taylor S; Debnam M; Feng L; Suki D; Karp D; Stewart D; Oh Y
J Thorac Oncol; 2009 Mar; 4(3):333-7. PubMed ID: 19190519
[TBL] [Abstract][Full Text] [Related]
2. An evidence-based review of the incidence of CNS bleeding with anti-VEGF therapy in non-small cell lung cancer patients with brain metastases.
Sandler A; Hirsh V; Reck M; von Pawel J; Akerley W; Johnson DH
Lung Cancer; 2012 Oct; 78(1):1-7. PubMed ID: 22877947
[TBL] [Abstract][Full Text] [Related]
3. Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases.
Mujoomdar A; Austin JH; Malhotra R; Powell CA; Pearson GD; Shiau MC; Raftopoulos H
Radiology; 2007 Mar; 242(3):882-8. PubMed ID: 17229875
[TBL] [Abstract][Full Text] [Related]
4. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA
Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of sunitinib in patients with non-small cell lung cancer and irradiated brain metastases.
Novello S; Camps C; Grossi F; Mazieres J; Abrey L; Vernejoux JM; Thall A; Patyna S; Usari T; Wang Z; Chao RC; Scagliotti G
J Thorac Oncol; 2011 Jul; 6(7):1260-6. PubMed ID: 21610524
[TBL] [Abstract][Full Text] [Related]
6. Gamma knife radiosurgery for the management of cerebral metastases from non-small cell lung cancer.
Bowden G; Kano H; Caparosa E; Park SH; Niranjan A; Flickinger J; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):766-72. PubMed ID: 25658792
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance (MR) patterns of brain metastasis in lung cancer patients: correlation of imaging findings with symptom.
Jena A; Taneja S; Talwar V; Sharma JB
J Thorac Oncol; 2008 Feb; 3(2):140-4. PubMed ID: 18303434
[TBL] [Abstract][Full Text] [Related]
8. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis.
Hu C; Chang EL; Hassenbusch SJ; Allen PK; Woo SY; Mahajan A; Komaki R; Liao Z
Cancer; 2006 May; 106(9):1998-2004. PubMed ID: 16572401
[TBL] [Abstract][Full Text] [Related]
9. Increased survival with the combination of stereotactic radiosurgery and gefitinib for non-small cell lung cancer brain metastasis patients: a nationwide study in Taiwan.
Lin CH; Hsu KH; Chang SN; Tsou HK; Sheehan J; Sheu ML; Pan HC
Radiat Oncol; 2015 Jun; 10():127. PubMed ID: 26048754
[TBL] [Abstract][Full Text] [Related]
10. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
[TBL] [Abstract][Full Text] [Related]
12. Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection?
Carolan H; Sun AY; Bezjak A; Yi QL; Payne D; Kane G; Waldron J; Leighl N; Feld R; Burkes R; Keshavjee S; Shepherd F
Lung Cancer; 2005 Jul; 49(1):109-15. PubMed ID: 15949596
[TBL] [Abstract][Full Text] [Related]
13. Brain Metastases at Presentation in Patients With Non-Small Cell Lung Cancer.
Waqar SN; Waqar SH; Trinkaus K; Gadea CA; Robinson CG; Bradley J; Watson MA; Puri V; Govindan R; Morgensztern D
Am J Clin Oncol; 2018 Jan; 41(1):36-40. PubMed ID: 26359696
[TBL] [Abstract][Full Text] [Related]
14. Safety of long-term anticoagulation in patients with brain metastases.
Horstman H; Gruhl J; Smith L; Ganti AK; Shonka NA
Med Oncol; 2018 Mar; 35(4):43. PubMed ID: 29497873
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of clinical N0 metastatic non-small cell lung cancer.
Tamura T; Kurishima K; Watanabe H; Shiozawa T; Nakazawa K; Ishikawa H; Satoh H; Hizawa N
Lung Cancer; 2015 Jul; 89(1):71-5. PubMed ID: 25913230
[TBL] [Abstract][Full Text] [Related]
16. Factors for incidence risk and prognosis in non-small-cell lung cancer patients with synchronous brain metastasis: a population-based study.
Zhu H; Zhou L; Guo Y; Yang G; Dong Q; Zhang Z; Chen M; Yang Q
Future Oncol; 2021 Jul; 17(19):2461-2473. PubMed ID: 33706557
[TBL] [Abstract][Full Text] [Related]
17. Risk of cerebral metastases for postoperative locally advanced non-small-cell lung cancer.
Wang SY; Ye X; Ou W; Lin YB; Zhang BB; Yang H
Lung Cancer; 2009 May; 64(2):238-43. PubMed ID: 18838190
[TBL] [Abstract][Full Text] [Related]
18. Who may benefit from prophylactic cranial irradiation amongst stage III non-small cell lung cancer patients?
Alsan Cetin I; Akgun Z; Atasoy BM; Fulden Yumuk P; Abacioglu U
J BUON; 2013; 18(2):453-8. PubMed ID: 23818361
[TBL] [Abstract][Full Text] [Related]
19. Brain: the common site of relapse in patients with pancoast or superior sulcus tumors.
Shah H; Anker CJ; Bogart J; Graziano S; Shah CM
J Thorac Oncol; 2006 Nov; 1(9):1020-2. PubMed ID: 17409988
[TBL] [Abstract][Full Text] [Related]
20. Suspected non-small cell lung cancer: incidence of occult brain and skeletal metastases and effectiveness of imaging for detection--pilot study.
Earnest F; Ryu JH; Miller GM; Luetmer PH; Forstrom LA; Burnett OL; Rowland CM; Swensen SJ; Midthun DE
Radiology; 1999 Apr; 211(1):137-45. PubMed ID: 10189463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
